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Abstract. In this paper, we consider a quasi non-linear reaction-diffusion model designed to mimic tumor cells’
proliferation and migration under the influence of their micro-environment in vitro. Since the model can be used
to generate hypotheses regarding the development of drugs which confine tumor growth, then considering the
composition of the model, we modify the model by incorporating realistic effects which we believe can shed more
light into the original model. We do this by extending the quasi non-linear reaction-diffusion model to a system
of discrete delay quasi non-linear reaction-diffusion model. Thus, we determine the steady states, provide the
conditions for global stability of the steady states by using the method of upper and lower solutions and analyze
the extended model for the existence of Hopf bifurcation and present the conditions for Hopf bifurcation to occur.
Since it is not possible to solve the models analytically, we derive, analyze, implement a fitted operator method
and present our results for the extended model. Our numerical method is analyzed for convergence and we find
that is of second order accuracy. We present our numerical results for both of the models for comparison purposes.
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1. Introduction
The study of cancer disease has led to the development of many cancer models see for in-
stance [14]. Most of the models are developed with one common goals, that is to understand
how cancer cells functions. Since a cure to cancerous diseases is still not found, this makes the
study of cancer disease an ongoing process. As a result of that, in this paper we are interested in
the the study of an interaction of tumor cells, within its own micro-environment. We note that
such studies has led to the development of many research work such as optimal control for math-
ematical models of cancer therapies in [40], computational modeling of interactions between
multiple myeloma and the bone micro-environment in [45], the role of the micro-environment
in tumor growth and invasion in [24] and current trends in mathematical modeling of tumor-
micro-environment interactions: a survey of tools and applications in [34] in the past few recent
years. Thus, before highlighting the system of non linear reaction-diffusion models modeling
an in-vitro situation of tumor cells and their micro-environment with regard to its growth and
metastasis derived and experimented in [23] and simulated in [12], we would like to mention
that Friedman and Kim in [12] mentioned that tumor cells proliferate at different rates and mi-
grate in different patterns depending on the micro-environment in which they are embedded.
Thus, further work done in the direction of tumor cells embedded in their micro-environments,
are for instance the establishment in [6] that as a tumor invades an unsuspecting host, an ac-
cumulation of evidence points to an alternative paradigm, where the tumor micro-environment
is not an idle bystander, but actively participates in tumor progression and metastasis. In fact,
stromal cells and their cytokines coordinate critical pathways that exert important roles in the
ability of tumors to invade and metastasize. More information regarding the actively partici-
pation of tumor micro-environment in tumor progression and metastasis can also be traced in
[4, 26]. Thus understanding the relationship between tumor and its micro-environment may
lead to important new therapeutic approaches in controlling the growth and metastasis of can-
cer. However, tumor micro-environment includes various cell types such as epithelial cells,
fibroblasts, myofibroblasts, endothelial cells, and inflammatory cells. These cells communi-
cate with one another and influence each other behavior by means of the cytokines and growth
TUMOR CELLS DYNAMICS 3
factors they secrete. Thus, in an effort to understand the interaction between tumor cells, fibrob-
lasts and/or myofibroblasts at an early stage of cancer, Friedman and Kim in [12] simulated the




































































































, −L/2 < x < L/2,

(1)
where transformed epithelial cells (TECs) and fibroblasts, myfibroblasts are denoted by n and
f ,m respectively, in equation (1), are placed in a trans-well, separated by a semi-permeable
membrane. The membrane has small micro-holes (≈ 0.4µm diameter) to allow the epidermal
growth factor (EGF) and transformed growth factor (TGF-β )) to pass through the membrane
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from one compartment to another. These molelcules are denoted by E and G, respectively, and
the length of the compartment is denoted by L in equation (1). Friedman and Kim [12] main
conclusions’ are
(i) fibroblasts enhance proliferation of breast cancer cell lines,
(ii) transformed epithelial cells (TECs) population is sensitive to membrane permeability
and to the transformation rate from fibroblasts to myofibroblasts,
(iii) interaction between transformed epithelial cells (TECs) and fibroblasts promotes not
only transformed epithelial cells (TECs) proliferation but also the proliferation of fi-
broblasts and/or myofibroblasts and the transformation from fibroblasts into myofibrob-
lasts.
Eventhough Friedman and Kim [12], did not present their simulation results explicitly, we re-
alised that thier findings are in agreement with assertion in [7, 22], that when epithelial cells
are in the breast duct, they are transformed by genetic mutations, from which they begin to
form aggregates that secrete higher concentrations of transformed growth factor (TGF-β ) and
this results into transformation of fibroblasts into myofibroblasts. Consequently, the increased
concentration of transformed growth factor (TGF-β ) also triggers the fibroblasts and myofi-
broblasts to secrete higher concentrations of epidermal growth factor (EGF) than in a healthy
tissue.
Thus, to capture the higher concentrations of epidermal growth factor (EGF), we believe one
has to consider the time required for a complete aggregation of the epithelial cells through the
secretion of higher concentrations of epidermal growth factor (EGF) than in a healthy tissue.
Denoting the required time by τ , this implies that we extend the quasi non-linear reaction-
diffusion model simulated in [12] to mimic tumor cells’ proliferation and migration under the
influence the micro-environment in vitro in equation (1), to a discrete delay quasi non-linear
reaction-diffusion model

















































+a21G(x, t− τ) f (x, t− τ)
















+a51n(x, t− τ)−a52G, −L/2 < x < L/2,

(2)
with uniform delay τ . We do not include a delay term τ , in the first equation in equation (2)
because we believe the attraction of transformed epithelial cells (TECs) in the direction of the
concentration gradient of the epidermal growth factor (EGF) can be observed from the adjusted
terms. Thus, the time τ is required for the proliferation of fibroblast into myfibroblasts, which
in turn requires some time τ for an increased concentration of transformed growth factor (TGF-
β ) to triggers the fibroblasts and myofibroblasts to secrete higher concentrations of epidermal
growth factor (EGF) should reflects its effects in the growth of the transformed epithelial cells,
than in a healthy tissue.
Delay differential equations (DDEs) are widely used for analysis and predictions in various
areas of life sciences, see for instance [1], epidemiology see for instance [15], immunology
see for instance [35], physiology see for instance [38], and neural networks see for instance
[10, 18]. Since time-delays and/or time-lags, can be related to the duration of certain hidden
processes like the stages of the life cycle, the time between infection of a cell and the production
of new viruses, the duration of the infectious period, the immune period, then introduction of
such time-delays in a differential model significantly increases the complexity of the model.
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Therefore, our first aim in this paper is to investigate how the uniform time delay τ affects the
dynamics of the models in equation (4). By applying the Poincaré normal form and the center
manifold theorem as in [16] we find conditions on the functions and derive formulas which
determine the properties of Hopf bifurcation. More specifically, we show that the semi-positive
equilibrium point losses its stability and the system exhibits Hopf bifurcation under certain
conditions. Considering the stiffness of system of equations in equation (4), our second aim
is therefore, to develop a fitted operator numerical method based on the qualitative features of
the models in equation (4), in such a way that the numerical method has wider stability region
despite the computational complexities associated with it.
Therefore, the boundary conditions for the original model remain unchanged as provided in
[12]. That is the fact that the semi-permeable membrane allows concentrations of epidermal
growth factor (EGF) and transformed growth factor (TGF-β ) to cross over, is represented by




·υ = 0 at x = 0+,


























E+(x) if x > 0,
E−(x) if x < 0,
G(x) =

G+(x) if x > 0,
G−(x) if x < 0,
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υ is the outward normal, and γ is a positive parameter which is determined by the size and
density of the holes in the membrane. The initial conditions [23] become
n(x,0) = 1.0exp(−40(x−1.0)2), on [0,L/2]× [−τ,0],
f (x,0) = 1.0exp(−40x2)r f , on [−L/2,0]]× [−τ,0],
m(x,0) = 0.00, on [−L/2,0]× [−τ,0],
E(x,0) = 1.0, on [−L/2,L/2]× [−τ,0],
G(x,0) = 1.0, on [−L/2,L/2]× [−τ,0].

(5)
The rest of the paper is organized as follow. Mathematical analysis of the main model is pre-
sented in Section 2. A robust numerical scheme based on the fitted finite difference technique
is formulated in Section 3, analysis of the basic properties of this scheme is also examined for
convergence. To justify the effectiveness of the proposed schemes, we present some numerical
results in Section 4. Section 5 concludes the paper.
2. Mathematical analysis of the model
In this section, we carry out the local stability and Hopf Bifurcation analysis and global
stability analysis of the steady states.
Local stability and Hopf Bifurcation analysis
At the steady states the in-vitro trans-well model in equation (2) becomes




4 n(1−n/κ) = 0, 0 < x < L/2,
−a21G f +a22 f = 0, −L/2 < x < 0,
a21G f +a31m = 0, −L/2 < x < 0,
a41 f +Ba41m−a43E = 0, −L < x < L,




n∗ = 0, n∗ = κ and G∗ = a51a52

0 if n∗ = 0,
a51
a52
κ, if n∗ = κ,
on 0 < x < L/2,
f ∗ = m∗ = 0, on −L/2 < x < 0,E∗ = 0, on −L/2 < x < L/2.

(7)
Therefore, the transwell model in equation (2) has a trivial equilibrium (0,0,0,0,0) and a semi-
positive equilibrium (κ,0,0,0, a51a52 κ). To analyze the stability of the semi-positive equilibrium
(κ,0,0,0, a51a52 κ), the first step is to linearize the in-vitro trans-well model in equation (2) at the


























































(n, f ,m,E,G)T : (n, f ,m,E,G) ∈C([−L/2,L/2]),R
}
,
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for φ = (φ1,φ2,φ3,φ4,φ5)T ∈C([−τ,0],X). The characteristic equation of equation in (8) is
λy−d∆−L(exp(λy) = 0, where y ∈ dom(d∆), y 6= 0.(10)
Since the boundary conditions in equation (3-4) are of Nuemann type, then the operator−∆ has
eigenvalues 0 = µ1 ≤ µ2 ≤ µ3 ≤ µ4 . . .µi ≤ µi+1 ≤ . . . and limi→∞ µi = ∞, with the correspond-














into equation (10) we obtain
0φ1(0)−Dnµi
a22−D f µi−a21G∗ exp(−λτ)−a21 f ∗ exp(−λτ)
a31−Dmµi +a21G∗ exp(−λτ)+a21 f ∗ exp(−λτ)



















The stability of the positive equilibrium can be determined by the distribution of the roots of
(13). It is locally asymptotically stable if all the roots of equation (12) have negative real parts
for all i = 0,1,2,3, . . . . Obviously, zero is not a root of (12) for all i = 0,1,2,3, . . . . When τ = 0,
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we obtain the eigenvalues as
λ =−Dnµi,−D f µi−a21G∗+a22,−Dmµi +a31,−Deµi,−Dgµi.(13)
The eigenvalues in equation (13) are unconditionally asymptotic stable for the steady state
(0,0,0,0,0) and conditionally asymptotic stable for the steady state (κ,0,0,0, a51a52 κ) when a22 <
a21a51
a52
κ . Thus, the following results.
Theorem 2.1.
(i) The trivial (0,0,0,0,0) steady state is unconditional asymptotic stable.
(ii) If a22 <
a21a51
a52
κ holds, the interior equilibrium (κ,0,0,0, a51a52 κ) of the transwell model
in equation (2) is asymptotically stable.
When τ 6= 0, we assume that λ = iω,(ω > 0). In view of equation (13), we have
iω +D f µk +a21G∗(cos(ωτ)+ isin(ωτ))−a22 = 0,(14)
Separating the real and imaginary parts in equation (14), we have











, ∀i = 0,1,2,3, . . . ,(16)
















Squaring on both sides of equation (15), we have
ω
2 +2ωa21G∗ sin(ωτ)+(a21G∗)2 sin2(ωτ) = 0,
(D f µk−a22)2 +2(D f µk−a22)(a21G∗ cos(ωτ))+(a21G∗)2 cos2(ωτ) = 0,(18)
Adding the two equations in (18) and simplify we obtain
ω =
√
3(D f µk−a22)2 +(a21G∗).(19)
Let τ0 = min{τi}, the we are able to state the following results.
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Lemma 2.1.
(i) If a22 <
a21a51
a52
κ hold for i = 0,1,2, . . . , then the equilibrium (κ,0,0,0, a51a52 κ) of the
transwell model in equation (2) is asymptotically stable for all τ ≥ 0.
(ii) If 0≤ τ0, then the equilibrium (κ,0,0,0, a51a52 κ) of the transwell model in equation (2) is
asymptotically stable.
(iii) If τ > τ0, then the equilibrium (κ,0,0,0,
a51
a52
κ) of the transwell model in equation (2) is
unstable.
(iv) The transwell model in equation (2) undergoes a Hopf bifurcation at the equilibrium
(κ,0,0,0, a51a52 κ) for τ = τi, where i = 0,1,2, . . . .
Global stability analysis
In this section we mainly prove that the equilibrium (κ,0,0,0, a51a52 κ) is globally asymptoti-
cally stable with the upper and lower solution method in [30, 31]. Let ϑE = E
4
k4E+E
4 , then denoting
the reaction functions in equation (2) by h j(n, f ,m,E,G) for j = 1,2,3,4,5, then from equation
(6) we have
h1 = a11ϑEn(1−n/κ) = 0, 0 < x < L/2,
h2 =−a21G f +a22 f = 0, −L/2 < x < 0,
h3 = a21G f +a31m = 0, −L/2 < x < 0,
h4 = a41 f +Ba41m−a43E = 0, −L/2 < x < L/2,
h5 = a51n−a52G = 0, −L/2 < x < L/2,

(20)
and let S⊂ R5+ such that S = {u ∈ R5+ : u≤ 0≤ ū} and K j be any positive constant satisfying




: u = (n, f ,m,E,G) ∈ S
}
, j = 1,2,3,4,5.
then we have the following results.





































































n(x, t) = K1, limt→∞ f (x, t) = K2, limt→∞ m(x, t) = K3,
lim
t→∞
E(x, t) = K4, limt→∞ G(x, t) = K5.
Theorem 2.2. If a22 < a21a51a52 κ for the transwell model in equation (2) implies that the equilib-
rium (κ,0,0,0, a51a52 κ) is globally asymptotically stable.
Proof: From the maximum principle of parabolic equations, it is known that for any initial
value (n0(t,x), f0(t,x),m0(t,x),E0(t,x),G0(t,x))> (0,0,0,0,0) the corresponding non-negative




then we choose ε0 ∈ (0,1). Then according to Lemma (2.2.) and the comparison principle of
parabolic equations, there exists t1 > 0 such that, for any t > t1,
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n(x, t)≤ K1 + ε0 := n̄(x, t), 0 < x < L/2,
f (x, t)≤ K2 + ε := f̄ (x, t), −L/2 < x < 0,
m(x, t)≤ K3 + ε := m̄(x, t), −L/2 < x < 0,
E(x, t)≤ K4 + ε := Ē(x, t), −L/2 < x < L/2,




n(x, t)≥ K1− ε0 := n(x, t), 0 < x < L/2,
f (x, t)≥ K2− ε := f (x, t), −L/2 < x < 0, ,
m(x, t)≥ K3− ε := m(x, t), −L/2 < x < 0,
E(x, t)≥ K4− ε := E(x, t), −L/2 < x < L/2,
G(x, t)≥ K5− ε := G(x, t), −L/2 < x < L/2.

(23)
Thus, for t > t0, it is possible to obtain
n(x, t) ≤ n(x, t)≤ n̄(x, t), 0 < x < L/2, f (x, t)≤ f (x, t)≤ f̄ (x, t), −L/2 < x < 0,
m(x, t) ≤ m(x, t)≤ m̄(x, t), −L/2 < x < 0, E(x, t)≤ E(x, t)≤ Ē(x, t), −L/2 < x < L/2,
G(x, t) ≤ G(x, t)≤ Ḡ(x, t), −L/2 < x < L/2.
Since h j(n, f ,m,E,G) in equation (20) is a C1 function of n, f ,m,E,G, where h1 is quasi-
monotone non-decreasing in f ,m,E,G, h2 is quasi-monotone non-increasing in n,m,E,G, h3 is
quasi-monotone non-increasing in n, f ,E,G, h4 is quasi-monotone non-decreasing in n, f ,m,G
and h5 is quasi-monotone non-decreasing in n, f ,m,E, then by the method of upper and lower
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solutions we know that the system in (2) has a unique global non-negative solution n, f ,m,E,G,
[30]. Thus,




Ē4n̄(1− n̄)≤ 0≤ a11κ En(1−n), 0 < x < L/2,
−a21G f̄ +a22 f̄ ≤ 0≤−a21Ḡ f +a22 f , −L/2 < x < 0,
a21G f +a31m̄≤ 0≤ a21Ḡ f̄ +a31m, −L/2 < x < 0,
a41 f̄ +Ba41m̄−a43Ē ≤ 0≤ a41 f +Ba41m−a43E, −L < x < L,
a51n̄−a52Ḡ≤ 0≤ a51n−a52G, −L < x < L.

(25)
Therefore, (n̄, f̄ , m̄, Ē, Ḡ) and (n, f ,m,E,G), are a pair of coupled upper and lower solutions of
system (2),[50], respectively. Thus, for any (n, f ,m,E,G)≤ (n1, f1,m1,E1,G1) and
(n2, f2,m2,E2,G2)≤ (n̄, f̄ , m̄, Ē, Ḡ) we have∣∣∣a11E41 n1k4E+E41 (1− n1κ )− (a11E42 n2k4E+E42 (1− n2κ ))∣∣∣≤ K(|E1−E2|+ |n1−n2|),0 < x < L/2,
|−a21G1 f1 +a22 f1− (−a21G2 f2 +a22 f2)| ≤ K(|G1−G2|+ | f1− f2|),−L/2 < x < 0,
|a21G1 f1 +a31m1− (a21G2 f2 +a31m2)| ≤ K(G1−G2|+ |m1−m2|) = 0,−L/2 < x < 0,
|a41 f1 +Ba41m1−a43E1− (a41 f2 +Ba41m2−a43E2))≤ K( f1− f2|+ |m1−m2|),−L < x < L,
|a51n1−a52G1− (a51n2−a52G2)| ≤ K(|n1−n2|+ |G2−G2|),−L < x < L.

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Defining two iteration sequences (n̄, f̄ , m̄, Ē, Ḡ) and (n, f ,m,E,G) for i≥ 1,
n̄(i) = n̄(i−1)+(a11
κ
Ē(i−1)n̄(i−1)(1− n̄(i−1)))/K, 0 < x < L/2,
f̄ (i) = f̄ (i−1)+(−a21G(i−1) f̄ (i−1)+a22 f̄ (i−1))/K,
m̄(i) = m̄(i−1)+(a21G(i−1) f (i−1)+a31m̄(i−1))/K, −L/2 < x < 0,
Ē(i) = Ē(i−1)+(a41 f̄ (i−1)+Ba41m̄(i−1)−a43Ē(i−1))/K, −L < x < L,





1 ))/K, 0 < x < L/2,
f (i) = f (i−1)+(−a21Ḡ(i−1) f (i−1)+a22 f (i−1))/K, −L/2 < x < 0,
m(i) = m(i−1)+(a21Ḡ(i−1) f̄ (i−1)+a31m(i−1))/K, −L/2 < x < 0,
E(i) = E(i−1)+(a41 f (i−1)+Ba41m(i−1)−a43E(i−1))/K, −L < x < L,
G(i) = G(i−1)+(a51n(i−1)−a52G(i−1))/K, −L < x < L,

(26)
where (n̄(0), f̄ (0), m̄(0), Ē(0), Ḡ(0))= (n̄, f̄ , m̄, Ē, Ḡ) and (n(0), f (0),m(0),E(0),G(0))= (n, f ,m,E,G).
Thus, for i≥ 1
(n, f ,m,E,G)≤ (n(i), f (i),m(i),E(i),G(i))≤ (n(i+1), f (i+1),m(i+1),E(i+1),G(i+1))
≤ (n̄(i+1), f̄ (i+1), m̄(i+1), Ē(i+1), Ḡ(i+1) ≤ (n̄(i), f̄ (i), m̄(i), Ē(i), Ḡ(i))≤ (n̄, f̄ , m̄, Ē, Ḡ),
and there exist (ñ(0), f̃ (0), m̃(0), Ẽ(0), G̃(0))> (0,0,0,0,0) and
(n̂(0), f̂ (0), m̂(0), Ê(0), Ĝ(0))> (0,0,0,0,0) such that
lim
i→∞
n̄ = ñ, lim
i→∞
f̄ = f̃ , lim
i→∞
m̄ = m̃, lim
i→∞






n = n̂, lim
i→∞
f = f̂ , lim
i→∞
m = m̂, lim
i→∞
E = Ê, lim
i→∞
G = Ĝ,




Ẽñ(1− ñ) = 0, a11
κ
Ên̂(1− n̂) = 0, 0 < x < L/2,
−a21Ê f̃ +a22 f̃ = 0, −a21G̃ f̂ +a22 f̂ = 0, −L/2 < x < 0,
a21Ĝ f̂ +a31m̃ = 0, a21G̃ f̃ +a31m̂ = 0, −L/2 < x < 0,
a41 f̃ +Ba41m̃−a43Ẽ = 0, a41 f̂ +Ba41m̂−a43Ê = 0, −L < x < L,
a51ñ−a52G̃ = 0 a51n̂−a52Ĝ = 0, −L < x < L.

(27)
Since, (κ,0,0,0, a51a52 κ) is the unique positive constant equilibrium of system (2), it must hold
for




Thus, by [30, 31], the solution (n(x, t), f (x, t),m(x, t),E(x, t),G(x, t)) of system (2) satisfies
lim
t→∞
n(x, t) = n∗, lim
t→∞
f (x, t) = f ∗, lim
t→∞
m(x, t) = m∗, lim
t→∞
E(x, t) = E∗,
lim
t→∞
G(x, t) = G∗.(29)
Hence, the constant equilibrium (κ,0,0,0, a51a52 κ) is globally asymptotically stable.
3. Derivation and analysis of the numerical method
In this section, we describe the derivation of the fitted operator method for solving the
system in equation (2). We determine an approximation to the derivatives of the functions
n(t,x), f (x, t),m(x, t),E(x, t),G(x, t), with respect to the spatial variable x.
Let Sx be a positive integer. Discretize the interval [−L/2,L/2] through the points
−L/2 = x0 < x1 < x2 < · · ·< xs−1 < xs < xs+1 · · ·< xSx−2 < xSx−1 < xSx = L/2,
where the step-size ∆x = x j+1− x j = (L/2+L/2)/Sx, j = 0,1, . . . ,xSx . Let
N j(t),F j(t),M j(t),E j(t),G j(t),(30)
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denote the numerical approximations of n(t,x), f (x, t),m(x, t),E(x, t),G(x, t). Then we approx-
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(·) j+1− (·) j
∆x
, D−(·) j =
(·) j− (·) j−1
∆x
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Let St be a positive integer and ∆t = T/St where 0 < t < T . Discretizing the time interval [0,T ]
through the points
0 = t0 < t1 < · · ·< tSt = T,
where
ti+1− ti = ∆t, i = 0,1, . . . ,(tSt −1).
We approximate the time derivative at ti by
∂n

































ψ f = (1− exp(−a22∆t))/a22, ψE = (1− exp(−a43∆t))/a43,
ψG = (1− exp(−a52∆t))/a52,ψm = (1− exp(−a31∆t))/a31,
where we see that ψ f →∆t,ψE→∆t,ψG→∆t, ψm→∆t as ∆t→ 0. The denominator functions
in equations (31) and (32) are used explicitly to remove the inherent stiffness in the central
finite derivatives parts and can be derived by using the theory of nonstandard finite difference
methods, see, e.g., [28, 32, 33] and references therein.
Combining the equation (31) for the spatial derivatives with equation (32) for time deriva-
tives, we obtain
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), x ∈ [xs,L/2],










+a22(H f )ij, x ∈ [−L2 ,xs],

































j , x ∈ [−L2 ,xs],









= a41(H f )ij +Ba41(Hm)
i
j−a43E ij , x ∈ [−L2 ,
L
2 ],















































































 E iL2 +1−E iL2−1
2∆xλE
2
 , F ixs+1 = F ixs−1,






























N 0x j = exp(−40(x j−1)
2), F 0x j = exp(−40x
2
j)r f , M
0
x j = 0.00, E
0
x j = G
0
x j = 1.00,

(33)
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where,the no-flux boundary conditions are discretised by means of the central finite difference
[5], j =−L/2,2, . . . ,L/2−1, i = 0,1, . . . ,T −1 and
(Hn)
i
j ≈ N(ti− τ,x j), (H f )ij ≈ F(ti− τ,x j), (HG)ij ≈ G(ti− τ,x j),
(Hm)
i
j ≈ M(ti− τ,x j),(34)
are denoting the history functions corresponding to n, f ,m,G. The system in equation (33) can

















j )√√√√1+(D−x E ij
λE
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which can be written as a tridiagonal system given by
AnN i+1j =−χn(D−x nij)
(D−x E
i
j )√√√√1+(D−x E ij
λE







N ij (1−N ij /κ)+
N ij
∆t ,

































































































On the interval [0,τ] the delayed arguments tn− τ belong to [−τ,0], and therefore the delayed





j ≈ n0(ti− τ,x j), (H f )ij ≈ f 0(ti− τ,x j), (Hm)ij ≈ m0(ti− τ,x j),
(HG)
i
j ≈ G0(ti− τ,x j),(38)
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and equation (36) becomes
AnN i+1j =−χn(D−x nij)
(D−x E
i
j )√√√√1+(D−x E ij
λE







N ij (1−N ij /κ)+
N ij
∆t ,









)2 −χmM ij D+x (D−x G ij)1+(D−x G ij
λG
)23/2
+a21G0(ti− τ,x) f 0(ti− τ,x)+a31M ij +
M ij
∆t ,
AEE i+1j = a41 f




AGG i+1j = a51n















j for 1≤ i≤ s. Up to this stage, we interpolate the data
(t0,N 0j ), (t1,N
1






j ), . . . ,(ts,F
s
j ),
(t0,M 0j ), (t1,M
1












j ), . . . ,(ts,G
s
j ),
using an interpolating cubic Hermite spline ϕ j(t). Then
N ij = ϕn(ti,x j), F
i
j = ϕ f (ti,x j), M
i
j = ϕm(ti,x j), E
i
j = ϕE(ti,x j) G
i
j = ϕG(ti,x j),
for all i = 0,1, . . . ,s and j =−L/2,2, . . . ,L/2−1.
For i = s+1,s+2, . . . ,T −1, when we move from level i to level i+1 we extend the defini-
tions of the cubic Hermite spline ϕ j(t) to the point
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j can be approximated by the functions
(ϕn) j(ti− τ),(ϕm) j(ti− τ),(ϕm) j(ti− τ),(ϕG) j(ti− τ) for i≥ s. This implies that,
(Hn)
i
j ≈ (ϕn) j(ti− τ), (H f )ij ≈ (ϕ f ) j(ti− τ), (Hm)ij ≈ (ϕm) j(ti− τ),
(HG)
i
j ≈ (ϕG) j(ti− τ),(40)
and equation (39) becomes
AnN i+1j =−χn(D−x nij)
(D−x E
i
j )√√√√1+(D−x E ij
λE







N ij (1−N ij /κ)+
N ij
∆t ,









)2 −χmM ij D+x (D−x G ij)1+(D−x G ij
λG
)23/2
+a21(ϕG)(ti− τ)(ϕ f )(ti− τ)+a31M ij +
M ij
∆t ,











ϕn(ti− τ) = [(Hn)i1,(Hn)i2 . . . ,(Hn)iL
2−1
















. . . ,(Hm)
i
x0−1]




. . . ,E iL
2−1
]′,
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Our FOFDM is then consists of equations (36)-(41). Rewriting the FOFDM as a system of
equations we have
AnN = Fn,
A f F = Ff ,
AmM = Fm,








j )√√√√1+(D−x E ij
λE







N ij (1−N ij /κ)+
N ij
∆t ,









)2 −χmM ij D+x (D−x G ij)1+(D−x G ij
λG
)23/2
+a21(ϕG)(ti− τ)(ϕ f )(ti− τ)+a31M ij +
M ij
∆t ,
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j− (Fn)ij = (An(n−N ))ij,
(ς f )
i
j = (A f f )
i



















maxi, j |nij−N ij | ≤ ||A−1n ||maxi, j |(ςn)ij|,
maxi, j | f ij−F ij| ≤ ||A
−1
f ||maxi, j |(ς f )ij|,
maxi, j |mij−M ij | ≤ ||A−1m ||maxi, j |(ςm)ij|,
maxi, j |E ij−E ij | ≤ ||A
−1
E ||maxi, j |(ςE)ij|,
maxi, j |Gij−G ij | ≤ ||A
−1
G ||maxi, j |(ςG)ij|,

(44)
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where




12 |nxxxx(ζ )|, x ∈ [xs,L/2],
maxi, j |(ς f )ij| ≤
(∆t)
2 | ft(ξ )|−D f
(∆x)2
12 | fxxxx(ζ )|, x ∈ [−
L
2 ,xs],




12 |nxxxx(ζ )|, x ∈ [−
L
2 ,xs],




















for ti−1 ≤ ξ ≤ ti+1 and x j−1 ≤ ζ ≤ x j+1. Moreover by [41] we have
||A−1n || ≤ Ξn, ||A−1f || ≤ Ξ f , ||A
−1
m || ≤ Ξm, ||A−1E || ≤ ΞE , ||A
−1
G || ≤ ΞG.(46)
Using (45) and (46) in (44), we obtain the following results.
Theorem 3.1. Let
Fn(x, t),Ff (x, t),Fm(x, t),FE(x, t),FG(x, t),
be sufficiently smooth functions so that n(x, t), f (x, t),m(x, t),E(x, t),G(x, t)∈C1,2([1,L]×[1,T ]).








j), j = 1,2, . . .L, i = 1,2, . . .T be the approximate solutions to (3), ob-


















j . Then there
exists Ξn,Ξ f ,Ξm,ΞE ,ΞG independent of the step sizes ∆t and ∆x such that
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maxi, j | f ij−F ij| ≤ Ξ f [
(∆t)
2 | ft(ξ )|−D f
(∆x)2
12 | fxxxx(ζ )|],

















and this conclude the analysis of our FOFDM.
4. Numerical results and discussions
We set xSx = tSt = 80 and time t = 25 or t = 30. Then using the parameter values in Table 1
([21]) we first take L = 5 < T = 20 and we present our numerical results of the model without
delay (1) in Figure 1 and Figure 2, respectively.
For L = T = 5 and time t = 25,30, we present our numerical results in Figure 3 (τ ≡ 0),
Figure 4 and for L = 20 > T = 5, our numerical results are presented in Figure 5 (τ ≡ 0) at time
t = 25.
Similarly, for L = 5 < T = 20, time t = 25 and τ = 5, we present our numerical results in
Figure 6 and for τ = 20 we present our results in Figure 7.
For L = 5 = T , time t = 25 and τ = 5, we present our numerical results in Figure 8, for
L = 20 = T we present our results in Figure 9, for t = 25 and τ = 15 and L = 20 = T we present
our results in Figure 10.
Finally, we present our numerical results for L = 20 > T = 5 at time t = 25 for τ = 5,25 in
Figure 11 and Figure 12.
In the figures for the original model in equation (1), that is Figure 1 to Figure 5 we see that
the behaviour for the fibroblasts and myfibroblasts are zero almost for entire portion of their
compartment, but eventually rise sharply near the end of the compartment in which they are
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embedded. One notable fact is the fibroblast grows to a very high hieght than the myfibroblasts.
However, for the Transformed epithelial cells we see the oscilations type of behaviour near
the preamable membrane when the compartment is lesser than or equal to the time taken for
the experiment. However, the oscillation decreases to one sharp peak when the length of the
compartment is greater than the the time to be taken for this experiment. For the excreted
molecules, we also see a bigger peaks as compare to the restricted cells for the case when the
length of the compartment is lesser, equal to the time required by this experiment. However,
when we increase the length of the compartment to be bigger than the the time required then
we see the excreted molecules grow sharply with slight decrease and increase till their turning
point toward the end of the compartment.
For the modified model in equation (2), that is from Figure 6 to Figure 12 we see the following
notable feautures. That is the osculations behaviour of the Transformed Epithelial cells are
prominent for the case of the compartment being lesser than the time required by this experiment
as compare to the behaviour of the vice versa of the length of the compartment to time required
by this experiment. However, for the fibroblasts and myfibroblast cells their behaviours remains
similar to that of the original model in equation (1). For the excreted molecules we see that
their concentration are inverted in Figure 6, as compare to their corresponding behaviours in
Figure 1. However, when we increase the delay, we see that the concentration of the Epidermal
growth factor smoothes out better than its behaviour when there is no delay. Similarly for the
concentration of the Transformed growth factor. These behaviours becomes more prominent as
we increases the delay around the specified length of the compartment and time.
In these experiments we see that the interaction of the two concentrations enhances the growth
of the Epidermal growth factor molecules. However, such an essential growth is more explicit
when a delay term is inclusive in the modeling of these nature.
5. Conclusion
In this paper, we consider a less complicated model simulated in [12] with the aim of shedding
more light into the interaction between transformed epithelial cells, fibroblasts and myfibrob-
lasts cells at an early stage of cancer disease. We deemed it essential to incorporate some of
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the crucial transformations ought to take take place during the experiment carried out in [23].
Such incorporation of some crucial transformations, led the original model to be transformed
to a system of non-linear delay parabolic partial differential equations. We analysed the re-
sulting system of non-linear delay parabolic partial differential equations and determined the
global stability conditions for our resulting system. Consequently, we were able to derive the a
fitted operator finite difference method (FOFDM) for solving the modified system in equation
(2). Our main findings are more vivid, eventhough they are indeed in agreement with the pre-
sented experimental results found in [12] as well as in [7, 22]. More essentially, the indirect role
played by the incorporation of a delay term (τ) in the extended model in equation (2) through
the behaviours of the molecules are more informative than what is presented in [12]. Thus, in
our views, this work should be seen as the first attempt to shed more light into the behavior
of the micro-environment of tumor cells, which in turn contributes toward understanding this
complicated infection.
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TABLE 1. Parameter values used for the transwell model
Dn = 3.6×10−4 χn = 3.6×10−8 λE = 1.00 a11 = 0.69
κ = 2.88×103 kE = 3.32 D f = 6.12×10−5 a21 = 2.61×10−2
a22 = 1.58×10−2 Dm = 6.12×10−4 χm = 3.96×10−6 a31 = 4.53×10−3
λG = 1.00 De = 5.98×10−1 a41 = 1.26 a43 = 2.89×10−2
B = 5.00 Dg = 3.6×10−1 a51 = 2.03×10−1 a52 = 2.89×10−2
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FIGURE 1. Numerical solution of the system in (2) without delay at time (t) =
25 for L < T .
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FIGURE 2. Numerical solution of the system in (2) without delay at time (t) =
30 for L < T .
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FIGURE 3. Numerical solution of the system in (2) without delay at time (t) =
25 for L = T .
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FIGURE 4. Numerical solution of the system in (2) without delay at time (t) =
30 for L = T .
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FIGURE 5. Numerical solution of the system in (2) without delay at time (t) =
25 for L > T .
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FIGURE 6. Numerical solution of the system in (2) with delay=5 for L < T .
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FIGURE 7. Numerical solution of the system in (2) with delay=20 for L < T at
time = 25.
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FIGURE 8. Numerical solution of the system in (2) with delay=5 for L = T at t = 25.
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FIGURE 9. Numerical solution of the system in (2) with delay=5 for L = T at t = 25.
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FIGURE 10. Numerical solution of the system in (2) with delay=15 for L = T
at t = 25.
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FIGURE 11. Numerical solution of the system in (2) with delay=5 for L > T at t = 25.
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FIGURE 12. Numerical solution of the system in (2) with delay=20 for L > T
at t = 25.
